Predrag Sikiric is being referenced as one of the leading scientists involved in the research and development of BPC-157
Research by Dhillo, Jayasena, and Comninos at Imperial College London has established that kisspeptin signaling is dysregulated in PCOS, and that administering exogenous kisspeptin can trigger coordinated LH surges in women with the condition.[8] A phase 2 trial demonstrated that subcutaneous kisspeptin administration successfully triggered ovulation in a proportion of women with PCOS who had not responded to conventional ovulation induction, including clomiphene citrate.[9] This is a genuinely novel therapeutic signal kisspeptin addresses a mechanism that metformin, combined oral contraceptives, and clomiphene do not touch
As of late, glutathione has emerged as one of the leading supplements to do just that
doi: 10.1210/endrev/bnaa023 11 AlseekhSAharoniABrotmanYContrepoisKDAuriaJEwaldJet al
The preclinical data are interesting enough to warrant proper human investigation, but it is not sufficient to justify self-experimentation
Invasive microorganisms or hazardous substances that are inhaled repeatedly can cause an excessive amount of ROS to be produced